The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast Cancer Screening Recommendations

Getty Images


May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast Cancer Screening Recommendations. The final United States Preventive Services Task Force (USPSTFBreast Cancer Screening Recommendations, while an improvement over previous guidance, do not go far enough to save more women’s lives.

The American College of Radiology will continue to urge the USPSTF to recommend all women have a breast cancer risk assessment by age 25 (as called for in ACR’s Breast Cancer Screening guidelines for high-risk women) and that women at average risk for breast cancer receive an annual mammography screening starting at age 40. Women at higher risk for breast cancer should talk to their doctor about starting screening prior to age 40 and additional screening methods.

The USPSTF, American College of Radiology, American Cancer Society, Society of Breast Imaging and others all agree that the most lives are saved with this annual approach. The ACR and SBI maintain their commitment to promote the value of annual screenings with mammography as stated in their joint average-risk guidelines. Medical experts must clear the confusion caused by differing recommendations.

Mounting evidence shows that Black and other minority women, Jewish women, and others develop and die from breast cancer prior to age 50 — or even age 40 — more often than white women. As our 2021 guidelines for average-risk women and our 2023 guidelines for high-risk women make clear, potentially giving cancer another year to advance may particularly impact these women.

Involving factors such as sex assigned at birth, hormone use and surgical history place transgender persons at increased risk for breast cancer. Biological females transitioning to male who do not undergo mastectomy remain at their previous risk for breast cancer and should continue to be screened as such. 

As outlined in current (2021) ACR/SBI recommendations for average-risk women, due to hormone use, biological males transitioning to female are at increased risk for breast cancer compared to other males and should speak with their doctor about their breast cancer risk.

ACR and SBI also recommend that women continue screening past age 74, unless severe comorbidities limit life expectancy. 

For more information: www.acr.org

Related content:

Leading Organizations and Breast Imaging Experts Weigh in on New Task Force Screening Recommendations, Impact on Health Equity and Women’s Health

Leading Organizations and Breast Imaging Experts Weigh in on New Task Force Screening Recommendations, Impact on Health Equity and Women’s Health


Related Content

News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
Subscribe Now